Maravai Lifesciences Holdings (MRVI) Total Debt Growth (1y) (2021 - 2026)
Maravai Lifesciences Holdings (MRVI) Total Debt Growth (1y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 788,338.31 Bn | 788,338.28 Bn | - | - |
| 2 | Belite Bio | 56,560.00 Bn | 56,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,329.30 Bn | 17,329.30 Bn | - | - |
| 4 | Legend Biotech | 3,341.00 Bn | 3,340.71 Bn | 242.10 Mn | 5.94% |
| 5 | Akari Therapeutics | 1,727.91 Bn | 1,727.91 Bn | - | - |
| 6 | Evaxion A | 1,536.68 Bn | 1,536.67 Bn | - | - |
| 7 | Psyence Biomedical | 238.34 Bn | 238.33 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.42 Bn | 106.17 Bn | 2.59 Bn | - |
| 9 | Abivax | 95.45 Bn | 95.45 Bn | - | - |
| 10 | Maravai Lifesciences Holdings | 747.50 Mn | 739.10 Mn | 33.70 Mn | -18.28% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -18.28% |
| Dec 31, 2025 | -1.41% |
| Sep 30, 2025 | -43.87% |
| Jun 30, 2025 | -43.76% |
| Mar 31, 2025 | -43.64% |
| Dec 31, 2024 | -43.54% |
| Sep 30, 2024 | -0.62% |
| Jun 30, 2024 | -0.62% |
| Mar 31, 2024 | -27.28% |
| Dec 31, 2023 | -0.62% |
| Sep 30, 2023 | -29.63% |
| Jun 30, 2023 | -0.63% |
| Mar 31, 2023 | 28.68% |
| Dec 31, 2022 | -5.72% |
| Sep 30, 2022 | 41.58% |
| Jun 30, 2022 | 0.23% |
| Mar 31, 2022 | 45.77% |
| Dec 31, 2021 | 4.64% |